Background {#Sec1}
==========

Atrial myxoma is the most common benign cardiac tumor, which represents about 50% of all primary cardiac tumors. Approximately 75% occur in the left atrium \[[@CR1]\]. Systemic embolism due to atrial myxoma has been well documented, especially embolic stroke \[[@CR2]\]. However, intracranial aneurysms are rarely associated to atrial myxoma \[[@CR3]\]. We present the case of a woman with dizziness and headache whose brain computed tomography angiography (CTA) manifested multiple fusiform aneurysms, and transthoracic echocardiography revealed a mass in the left atrium.

The pathogenesis of the cerebral vascular disease related to an atrial myxoma is still not well known, and there are no guidelines to guide treatment and anesthesia management in such patients.

Case presentation {#Sec2}
=================

Case report {#Sec3}
-----------

A 38-year-old woman with no medical history presented 10 days of dizziness and headache without loss of consciousness, dysarthria, weakness, nausea, or vomiting. Neurological examination was normal. The brain CTA manifested two unruptured fusiform aneurysms, which located in left anterior cerebral artery and left posterior cerebral artery, with the size of 9.7 mm × 6.3 mm and 10.2 mm × 7 mm, respectively (Fig. [1](#Fig1){ref-type="fig"}). Furthermore, transthoracic echocardiography (TTE) revealed a 4.8 × 2.9 × 2.5 cm^3^ mass attached to the interatrial septum in the left atrium, which obstructed the mitral orifice without mitral valve regurgitation (Fig. [2](#Fig2){ref-type="fig"}). Fig. 1Two fusiform aneurysms located in left anterior cerebral artery and left posterior cerebral artery, with the size of 9.7 mm × 6.3 mm and 10.2 mm × 7 mm, respectivelyFig. 2TTE revealed a 4.8 × 2.9 × 2.5 cm^3^ mass attached to the interatrial septum in the left atrium, which obstructed the mitral orifice without mitral valve regurgitation

According to the recommendation of multidisciplinary team (MDT), myxoma was first considered to be excised, a conservative approach was chosen for cerebral aneurysms, and the fast track cardiac surgery pathway should be performed to evaluate neurological function as soon as possible. The baseline vital signs of this patient were measured before induction of general anesthesia, in order to maintain the fluctuation range of heart rate (HR) and mean arterial pressure (MAP) within 10% throughout the perioperative period. The mass was successfully removed and histological examination confirmed a typical myxoma (Fig. [3](#Fig3){ref-type="fig"}). No mitral regurgitation or shunt flow across the atrial septum was revealed by transesophageal echocardiography (TEE) (Fig. [4](#Fig4){ref-type="fig"}). Parenchymal brain oxygen (PbtO~2~) monitoring did not change significantly throughout the procedure. The patient was transported to intensive care unit (ICU) receiving infusion of propofol. After that, continuous infusion of fentanyl (0.3μg/kg × h^− 1^) was performed to ensure analgesia and attenuate cardiovascular response to tracheal intubation. She was extubated 3 h after surgery without neurological disorder and discharged from ICU on the first day. Intravenous patient-controlled analgesia pump was employed to insure postoperative numeric rating scale (NRS) score lower than 3 (0 = No pain, 10 = worst pain imaginable) \[[@CR4]\]. She was fully recovered and discharged home on the sixth day after surgery. Fig. 3Polypoid type of atrial myxomaFig. 4After resection of myxoma, no mitral regurgitation or shunt flow across the atrial septum was revealed by transesophageal echocardiography

Review and analysis of the literature {#Sec4}
-------------------------------------

The keywords "cerebral aneurysm", "intracranial aneurysm", "myxoma", and "anesthesia" were used for searching in the PubMed and Google Scholar databases. The literature written in English published from January 1966 to April 2019 was reviewed, and articles or abstracts providing the following information were included, for instance, age, gender, intervention for myxoma and aneurysm, complication, and outcome. Eventually, there were 47 reports of 49 cases and a total of 50 cases analyzed \[[@CR3], [@CR5]--[@CR49]\]. The median age was 38 years (95%CI, 34--42), and female/male ratio was 3.17:1. Resection of atrial myxoma was performed first in 90% (45) cases. Among these, conservative therapy for cerebral aneurysm was performed in 70% (35) cases, including repeated operations of recurrence myxoma in 2 cases \[[@CR33], [@CR40]\]. Whereas, craniotomy for aneurysm in 3 cases \[[@CR8], [@CR11], [@CR19]\], coiling for 2 cases \[[@CR15], [@CR34]\], radiation for 1 case \[[@CR32]\], and cytostatic treatment for 1 case was carried out later \[[@CR12]\]. Only one case reported craniotomy was performed first and early resection of myxoma was advised \[[@CR13]\]. Three patients were dead in the early 1970s due to lack of knowledge and treatment \[[@CR45], [@CR46], [@CR48]\]. After resection of myxoma, 13.3% (6/45) patients suffered neurological dysfunction, while acute left hemiparesis appeared during induction of anesthesia and the operation was delayed in one case \[[@CR5]\]. Severe neurological complication appeared in one patient with chronic renal failure, who finally died of sepsis \[[@CR22]\]. No perioperative subarachnoid hemorrhage (SAH) was reported. Except in one patient, a conservative therapy was attempted, and a myxoma was verified by autopsy with cerebral aneurysms in 1973 \[[@CR45]\]. During follow-up period, the rates of stable and regression of aneurysm were 50% (25 cases) and 10% (5 cases) respectively, while enlargement was 10% (5 cases), and new formation was 12% (6 cases). The subgroup of 11 progressive cases was further analyzed, continuous conservative therapy was performed in 4 cases, operation was carried out in 3 cases, and radiotherapy was administered in one case. Further follow-up revealed stable or regression after the treatment. Only one patient suffered SAH \[[@CR21]\]. Although anesthesia management was introduced in only one case, it was in craniotomy procedure \[[@CR13]\].

Discussion and conclusions {#Sec5}
==========================

The incidence of primary heart tumors is less than 0.2% in patients. 75% of the tumors are benign, in which approximately 50% are myxomas \[[@CR1]\]. Nearly three quarters of myxomas are located in the left atrium, while 15 \~ 20% are in the right atrium. Up to 20% of patients can be asymptomatic, whereas in a large case series, mitral valve obstruction, systemic emboli, and constitutional symptoms occurred \[[@CR50], [@CR51]\]. Systemic emboli has been well documented, especially embolic stroke \[[@CR52], [@CR53]\]. It was reported a villous myxoma might be associated with more chances of metastasis of myxomas, and polypoid type was the only independent predictor of systemic emboli \[[@CR54]\]. However, cerebral aneurysms related to atrial myxoma are rare. This patient was asymptomatic with myxoma, and neurological symptoms appeared first, for instance, dizziness and headache. The myxoma was polypoid type in this case.

In 1894, Marchand first reported an interesting phenomenon that cerebral aneurysms were associated with atrial myxoma \[[@CR55]\]. Until 2005, Sabolek demonstrated the typical manifestation of aneurysms were multiple with fusiform shape \[[@CR27]\]. To date, only around 50 case reports written in English could be found in the literature (Table [1](#Tab1){ref-type="table"}). However, the exact mechanism is still not clear. The hypothesis of "Metastasize and Infiltrate" was considered as an essential mechanism for cerebral aneurysm formation. Myxoma cells may metastasize to the cerebral arteries, infiltrate into the vessel wall through the vasa vasorum or endothelial, interrupt the elastic lamina, and lead to aneurysm formation. Histological examination of the excised cerebral aneurysm verified this hypothesis \[[@CR29], [@CR36], [@CR48]\]. Recent reports proposed another hypothesis, which is inflammation reaction arised from myxoma. It is reported that new cerebral aneurysms can form after myxoma resection, without recurrent myxoma or embolism \[[@CR56]\]. Some studies found that new aneurysm formed with elevated proinflammation cytokines like interleukin-6 (IL-6) after resection of myxoma \[[@CR27]\]. What is more, IL-6 level upregulated by myxoma may contribute to aneurysm formation \[[@CR57], [@CR58]\]. Other researches illuminated that IL-6 could promote matrix metalloproteinases expression and activity, which enhance invasion of myxoma cells \[[@CR23], [@CR59]\]. Unfortunately, IL-6 level was not tested in our patient. Table 1Case reports of multiple aneurysms related to atrial myxomaAuthorYearAgeGenderProcedure (myxoma, aneurysm)ComplicationOutcome1This case201938FResection, ConservativeNoneDischarge 6 days postoperation and follow-up2Coutinho R, et al201846FResection, ConservativeAcute left hemiparesis during inductionAneurysms completely regressed 18 days later and follow-up3Penn DL, et al201812MResection, ConservativeNone1 year follow-up, growth of 2 aneurysms, hybrid procedure, 43 months follow-up, unchanged4Flores PL, et al201861MResection, ConservativeNone18 months follow-up, unchanged519FResection, ConservativeNone5 year follow-up, several enlarged, others regressed, asymptomatic, conservative6Yoo HJ, et al201820FResection, Craniotomy laterLost vision in right eyeNot mentioned7Quan K, et al201749FResection, ConservativeNot mentionedFurther intracranial lesions resection may be performed8Sveinsson O, et al201519FResection, ConservativeNone1 year follow-up, unchanged9Zheng J, et al201525FResection first, craniotomy 7 months laterDrowsiness and partial seizure 6 days after craniotomyDischarge 7 days later, 2 months follow-up, unchanged10201539FResection 20 years ago, ConservativeNone14 months follow-up, occastional dizziness11Vontobel J, et al201541FResection, Cytostatic treatmentNoneFollow-up, decreased tracer uptake in PET, stable aneurysm sizes12Srivastava S, et al201430FNone, Craniotomy firstNoneDischarge 7 days later, early resection of myxoma was advised13Xu Q, et al201346FResection, ConservativeNoneFollow-up14Al-Said Y, et al201367FResection, Coiling 1 week laterNone1 year follow-up, unchanged15Kim H, et al201258MResection, ConservativeNone1 year follow-up, unchanged16KJ George, et al201245FResection, ConservativeNoneDischarge 2 weeks later, 18 months follow-up, unchanged17Lee SJ, et al201255FResection, ConservativeNot mentioned47 months follow-up, asymptomatic18Radoi MP, et al201245FMyxoma 1 year ago, Craniotomy twice for 2 lesionsMinor neurological deficitsDischarge 3 weeks later, 12 months follow-up, unchanged19Chiang KH, et al201152FResection, ConservativeNone2 years follow-up, unchanged20Eddleman CS, et al201018MResection, ConservativeNot mentioned4 months follow-up, multiple aneurysms formated and hemmorrhage, 3 months later, several aneurysms enlarged and hemmorrhage21Koo YH, et al200965FResection, ConservativeNone6 months follow-up, unchanged22Shinn SH, et al200948FResection, ConservativeComplex-focal type of status epilepticusDead due to sepsis 22 days after surgery23Ryou KS, et al200827FResection, ConservativeIntermittent headache11 years follow-up, unchanged24Li Q, et al200827FResection, ConservativeNone2 years follow-up, unchanged25Kvitting JP, et al200855FResection, ConservativeNone6 months follow-up, unchanged26Sedat J, et al200750FResection, NoneNone5 years later aneurysms formated and radiation therapy, 1 year follow-up, one aneurysm regressed27Namura O,et al200735MResection, ConservativeRaynaud's phenomenon10 years follow-up, unchanged28Herbst M, et al200531MResection, ConservativeNone2 years follow-up, unchanged29Sabolek M, et al200543FResection, ConservativeNone15 months follow-up, one aneurysm regressed30Chen Z, et al200519FResection, NoneNone2 years later multiple aneurysms formated and conservative therapy, 1 year follow-up, unchanged31Josephson SA, et al200533FNot mentionedNot mentioned8 years follow-up, unchanged32Ashalatha R, et al200554MResection, NoneNone6 months follow-up, multiple aneurysms formated and Conservative therapy33Altundag MB, et al200541FResection, Radiation 1 year laterNone4 years follow-up, unchanged34Stock K, et al200422FResection 2 times, conservativeNone11 years follow-up, some aneurysms regressed and some aneurysms smaller, no new aneurysm35Yilmaz MB, et al200338FRecurrence and resection of myxoma, coil embolization for one giant aneurysmNoneFollow-up, unchanged36Furuya K, et al199535MResection, ConservativeNone19 months follow-up, enlarged and craniotomy, another 5 months follow-up, unchanged37Mattle HP, et al199549MResection, ConservativeNot mentioned5 years follow up, aneurysm formated 3 years after surgery, demented 5 years later and continuously progressed38Suzuki T, et al199434MResection, ConservativeNot mentionedFollow-up, aneurysm formated 2 months after surgery, and enlarged 5 months later39Chen HJ, et al199368FResection, ConservativeNot mentionedCraniotomy 1 year later, 2 years follow-up, unchanged40Hung PC, et al199210FResection, ConservativeNone8 months follow-up, unchanged41Bobo H, et al198715FResection four times for recurrent myxoma, ConservativeNone6 months follow-up, unchanged42Reed OM, et al198625FResection, ConservativeNot mentioned12 years follow-up, clip for a large aneurysm 9 years later43Branch CL, et al198553FResection, ConservativeNone18 months follow-up, one aneurysm disappeared44Leonhardt ET, et al197731MResection, ConservativeNone2 months follow-up, unchanged45Damásio H, et al197543FResection, ConservativeNone1 year follow-up, unchanged46Steinmetz EF, et al197348FConservative, ConservativeSAH and hematoma evacuationDead 2 months later, autopsy verified myxoma with cerebral aneurysms47Burton C, et al197041FNone, craniotomy firstNot mentionedDead in the first day after surgery48New PF, et al197041FResection, ConservativeNone8 years follow-up, unchanged49Price DL, et al197021FConservative, ConservativeNot mentionedDead 11 months later, autopsy verified myxoma with cerebral aneurysms50Stoane L, et al196629MResection, ConservativeNone2 months follow-up, slightly larger and conservative therapy

There are no clinical practice guidelines on such patients. Myxoma was suggested to be resected first to prevent systemic emboli and mitral valve obstruction \[[@CR1], [@CR10]\]. In the meantime, fusiform aneurysm is not suitable for clipping or coiling compared to saccular aneurysm, surgical procedure is still an important intervention \[[@CR60]\]. Fortunately, the SAH rate of multiple cerebral fusiform aneurysms related to atrial myxoma was low \[[@CR27]\]. In addition, it is reported that the cerebral aneurysms regressed after myxoma resection in some cases \[[@CR3], [@CR5]\]. Therefore, a conservative treatment approach for cerebral aneurysms was recommended by the preoperative MDT meeting.

Anesthesia management was an enormous challenge. Few piece of evidence was found in the database to guide optimal clinical anesthesia practice. The procedural strategy was to prevent ischemic and hemorrhagic stroke. Intraoperative cerebrovascular monitoring techniques remain controversial \[[@CR61]\]. PbtO~2~ monitoring was recommended to detect brain ischemia and intracranial hypertension in neurocritical care patients \[[@CR62]\]. As is known to all, the transmural pressure (TMP) of cerebral aneurysm is equal to cerebral perfusion pressure (CPP), which depends on mean arterial pressure (MAP) and intracranial pressure (ICP). $$\documentclass[12pt]{minimal}
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Therefore, an increase in MAP or a decrease in ICP will lead to an increase in CPP, which might increase the risk of rupture of aneurysm. On the contrary, a decrease in MAP or an increase in ICP will increase the risk of cerebral ischemia \[[@CR63]\]. Firstly, induction of general anesthesia was an important step. One patient was reported to develop an acute left hemiparesis during induction \[[@CR5]\]. Thus, it is crucial to control the TMP diligently. MAP and heart rate (HR) was recommended to close to baseline \[[@CR64]\]. Lidocaine is beneficial to such patients, which could not only blunt cerebral hemodynamic response to endotracheal intubation, but also attenuate proinflammatory effects \[[@CR65], [@CR66]\]. Besides, esmolol and fentanyl were demonstrated to prevent hemodynamic fluctuation related to intubation in a randomized controlled trial \[[@CR67]\]. Secondly, cardiopulmonary bypass (CPB) is a risk factor of stroke, whose pathophysiological mechanisms refer to hemorrhagic, global ischemia, and embolic \[[@CR68]\]. TEE plays a vital role in evaluating embolism originated from the heart \[[@CR69]\]. On the other hand, it is instrumental to detect the pathogenesis of hypotension, guide fluid replenishment and identify mitral regurgitation and shunt flow \[[@CR70]\]. With respect to SAH, perioperative hypertension and anticoagulation are common in the cardiac surgery \[[@CR68]\], which may increase the risk of aneurysm rupture. Although a most recent large observational study investigated the risk of postoperative 30-day SAH was 0.29%, not higher than general population \[[@CR71]\], it was suggested to decrease CPB time and intensively control the blood pressure \[[@CR68]\]. In addition, PaCO~2~ should be maintained at normal level, and hyperventilation, which will decrease ICP, should be avoided \[[@CR72]\]. In this case, the CPB time was 41 min, fluctuation range of MAP was within 10%, and PaCO~2~ was normal throughout the procedure. Thirdly, the fast track cardiac anesthesia was implemented to evaluate neurological function early after procedure, which aims to extubation within 1 \~ 6 h post-operation \[[@CR73]\]. However, tracheal extubation should be paid more attention, when tachycardia, hypertension and coughing frequently occur \[[@CR74]\]. And it would increase the risk of aneurysm rupture. Fentanyl attenuates cough and cardiovascular response effectively, which can be safely used in fast track cardiac anesthesia \[[@CR75]--[@CR77]\]. Fortunately, refined perioperative anesthesia management was performed in this rare case, and the patient recovered uneventfully.

Atrial myxoma-related cerebral aneurysms are always multiple and in a fusiform shape in most occasions. Early resection of myxoma and conservative therapy of aneurysm is an optimal treatment. It is a great challenge to anesthesiologists to prevent stroke perioperatively. TEE and PbtO~2~ monitoring play an essential role in anesthesia management. Fast track cardiac anesthesia is safe and effective to early evaluate neurological function. Long term follow-up for "myxomatous aneurysms" is recommended. And outcome of most patients is excellent. Further study is needed to reveal the mechanism of atrial myxoma resulting in multiple cerebral aneurysms.
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